PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Putting a human face on a product: When brand humanization goes wrong

2013-04-02
(Press-News.org) CORVALLIS, Ore. – When companies put a human face on their brand, the public usually responds positively. This advertising approach has brought us alarm clocks with sleepy faces and color-coated chocolate candies with legs and arms.

But a new study, published online ahead of print in the Journal of Marketing, finds there is a greater backlash by the public when a product branded with human characteristics fails.

Lead author Marina Puzakova, an assistant professor of marketing at Oregon State University, said even though consumers can tell a camera designed with human characteristics such as little eyes and legs isn't a person, the very act of humanizing a product can be a powerful tool.

"Somehow, now the product seems alive and mindful, and therefore can be perceived as having intentions and its own motivations to act in a certain way," Puzakova said. "This perception of intentions can be extremely strong – consumers now see the brand as performing bad intentionally and therefore consumers develop more negative sentiments toward the brand."

Puzakova conducted five experiments with products that had experienced negative publicity. As a general procedure, participants saw advertisements of both existing and fictitious products, where "human" characteristics, such as arms, legs, or facial-like features were manipulated. Then Puzakova showed participants news reports about how the product had failed in some way, not lived up to its advertising claim, or did not function based on consumer expectations.

In every instance, participants reported that they had stronger negative reactions to the products that were given human characteristics, also known as "brand anthropomorphization."

"Brand anthropomorphization can be a very powerful advertising tool, so I am definitely not saying that companies shouldn't use it," Puzakova said. "However, they need to be aware that when they imbue their products with human-like characteristics, any backlash when something goes wrong could be stronger."

Puzakova's study found that the strength of negative reactions depended on consumer personality differences as well. Based on a personality test she gave participants, she found that people who believe in "personality stability," or that personality traits are always the same and don't change over time, tended to have stronger negative feelings towards anthropomorphized brands.

"Broadly speaking, men tend to believe in personality stability more than women, and seniors as well," Puzakova said. "Also, some cultures tend to believe in this more than others. This can be important for advertisers to know, depending on who their target market is.

Having a deeper knowledge about their target markets, companies can also design their advertising communications tailored for different types of consumers. For example, marketers may want to emphasize flexibility and change in an ad campaign in order to reverse negative attitudes by male consumers, who tend to believe in personality stability.

Puzakova's research also has a lesson for companies whose brands fail because of a product malfunction.

"As consumers who believe in stability of personality traits react to product failures more negatively, our research finds that companies need to provide either monetary compensation or give away coupons," Puzakova said. "Offering a public apology is not enough. For instance, companies that have a humanized brand marketed heavily towards seniors may need to be prepared to generously compensate those consumers if something goes wrong."

The bottom line, Puzakova said, is companies need to know their audience and the possible dangers of humanizing a brand when a product malfunctions. It can be a powerful advertising tool, but if the product fails in some way, the damage control could be costly and timely.

Hyokjin Kwak of Drexel University and Joseph Rocereto of Monmouth University contributed to this study.



INFORMATION:



ELSE PRESS RELEASES FROM THIS DATE:

Diversification in ancient tadpole shrimps challenges the term 'living fossil'

2013-04-02
The term 'living fossil' has a controversial history. For decades, scientists have argued about its usefulness as it appears to suggest that some organisms have stopped evolving. New research has now investigated the origin of tadpole shrimps, a group commonly regarded as 'living fossils' which includes the familiar Triops. The research reveals that living species of tadpole shrimp are much younger than the fossils they so much resemble, calling into question the term 'living fossil'. Darwin informally introduced the term 'living fossil' in On the Origin of Species when ...

Tonsillectomy in adults with severe recurrent sore throats may benefit some people

2013-04-02
Tonsillectomy may result in fewer severe sore throats and could benefit some adult patients, according to a randomized trial published in CMAJ (Canadian Medical Association Journal). Recurrent severe sore throats result in lost work or school days and frequent use of antibiotics. Researchers from Finland conducted a randomized open trial to determine whether tonsillectomy reduced episodes of severe sore throats (pharyngitis). The trial involved 86 patients, 46 of whom had the procedure and 40 who did not. The primary outcome was the difference in the number of patients ...

Organ donation shortfall at large general hospitals in Ontario

2013-04-02
Organ donation in Ontario is significantly less common at large general hospitals than at hospitals with clinical programs for transplant recipients, which points to missed opportunities to optimize organ donation, according to a study published in CMAJ (Canadian Medical Association Journal). To understand whether organ donation rates differed between hospitals that treat transplant recipients and those that do not, researchers looked at all patients (adults and children) who died from catastrophic brain injury in Ontario between 1994 and 2011. After excluding small hospitals ...

Cholesterol rafts deliver drugs inside cancer cells

2013-04-02
DNA, siRNA and miRNA can reprogram cancer cells – that is, if these nucleic acids could cross through the cell membrane. A University of Colorado Cancer Center study published today in the journal Therapeutic Delivery shows that cholesterol "rafts" can shepherd genetic payloads into cancer cells. "There are many promising therapeutic applications for nucleic acids, but because they can't diffuse across cell membranes on their own, delivery to cancer cells has been a major challenge. Our method is a promising way to get these drugs inside cancer cells where they can do ...

Study reveals risk factors for blood clots in pregnant and postnatal women

2013-04-02
Women who have suffered a still birth or have medical conditions including varicose veins, inflammatory bowel disease (IBD) or heart disease are at greater risk of developing dangerous blood clots after giving birth, a study has revealed. The research, led by academics at The University of Nottingham, found that being obese, suffering bleeding during pregnancy or labour and having a premature birth or delivery via caesarean section also increased the risk of a venous thromboembolism (VTE). Their findings, published in the American Society of Hematology journal Blood, ...

Cartilage damaged from exercise may aid in early osteoarthritis detection

2013-04-02
Osteoarthritis is the most common joint disorder, affecting about one-third of older adults, and currently there is no cure. A study published by Cell Press April 2nd in the Biophysical Journal reveals how the nanoscale biomechanical properties of cartilage at joints change at the earliest stages of osteoarthritis, making the tissue more prone to damage during fast physical activities. The findings could improve early detection of the disease as well as tissue engineering strategies to repair damaged cartilage in patients. "Our techniques enable detection of the earliest ...

Cholesterol-lowering eye drops could treat macular degeneration

2013-04-02
VIDEO: This video transitions to where it goes inside the eyeball and scans the retina. The white/yellow circle is the optic nerve and the yellowish egg yolk colored deposits are the... Click here for more information. Macular degeneration is the leading cause of blindness in older Americans. Much-needed prevention and treatment strategies for this pervasive disease may soon be on the way, thanks to findings published by Cell Press on April 2nd in the journal Cell Metabolism. ...

The way of science

2013-04-02
New findings in mitochondrial biology thoroughly change the idea scientists had for 20 years on the role and importance of the protein MTERF1. For the first time, Max Planck researcher Mügen Terzioglu and her colleagues in Germany and Sweden investigated in vivo what was up to now only explored in cell culture. Using the mouse as a model organism, she made a surprising discovery: MTERF1 does after all not play the key role in mitochondrial transcription and translation that was hitherto ascribed to it. Dr Terzioglu's findings will change the way we look at the regulation ...

Bioglass helping to mend bones

2013-04-02
Jose Ramon Sarasua and Aitor Larrañaga, researchers in the materials engineering department of the UPV/EHU-University of the Basque Country, have been studying new materials or implants that are of interest in medicine and in helping to mend bones, in particular. They have in fact measured the effect that the bioglass has on the thermal degradation of polymers currently used in medicine. The results have been published in the journal Polymer Degradation and Stability. Bones are capable of regenerating themselves if they suffer slight damage. But if the damage is above ...

Cholesterol buildup links atherosclerosis and macular degeneration

2013-04-02
VIDEO: This is video of an examination of the retina of a patient with age-related macular degeneration. The light-colored flecks are cholesterol-rich deposits that have built up under the retina.... Click here for more information. A new study raises the intriguing possibility that drugs prescribed to lower cholesterol may be effective against macular degeneration, a blinding eye disease. Researchers at Washington University School of Medicine in St. Louis have found ...

LAST 30 PRESS RELEASES:

A unified model of memory and perception: how Hebbian learning explains our recall of past events

Chemical evidence of ancient life detected in 3.3 billion-year-old rocks: Carnegie Science / PNAS

Medieval communities boosted biodiversity around Lake Constance

Groundbreaking research identifies lethal dose of plastics for seabirds, sea turtles and marine mammals: “It’s much smaller than you might think”

Lethal aggression, territory, and fitness in wild chimpanzees

The woman and the goose: a 12,000-year-old glimpse into prehistoric belief

Ancient chemical clues reveal Earth’s earliest life 3.3 billion years ago

From warriors to healers: a muscle stem cell signal redirects macrophages toward tadpole tail regeneration

How AI can rig polls

Investing in nurses reduces physician burnout, international study finds

Small changes in turnout could substantially alter election results in the future, study warns

Medicaid expansion increases access to HIV prevention medication for high-risk populations

Arkansas research awarded for determining cardinal temps for eight cover crops

Study reveals how the gut builds long-lasting immunity after viral infections

How people identify scents and perceive their pleasantness

Evidence builds for disrupted mitochondria as cause of Parkinson’s

SwRI turbocharges its hydrogen-fueled internal combustion engine

Parasitic ant tricks workers into killing their queen, then takes the throne

New study identifies part of brain animals use to make inferences

Reducing arsenic in drinking water cuts risk of death, even after years of chronic exposure

Lower arsenic in drinking water reduces death risk, even after years of chronic exposure

Lowering arsenic levels in groundwater decreases death rates from chronic disease

Arsenic exposure reduction and chronic disease mortality

Parasitic matricide, ants chemically compel host workers to kill their own queen

Clinical trials affected by research grant terminations at the National Institutes of Health

Racial and ethnic disparities in cesarean birth trends in the United States

Light-intensity-dependent transformation of mesoscopic molecular assemblies

Tirzepatide may only temporarily suppress brain activity involved in “food noise”

Do all countries benefit from clinical trials? A new Yale study examines the data

Consensus on the management of liver injury associated with targeted drugs and immune checkpoint inhibitors for hepatocellular carcinoma (version 2024)

[Press-News.org] Putting a human face on a product: When brand humanization goes wrong